Literature DB >> 33297444

Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus.

Mehran Alavi1, Kofi Asare-Addo2, Ali Nokhodchi3.   

Abstract

The outbreak of a novel strain coronavirus as the causative agent of COVID-19 pneumonia, first identified in Wuhan, China in December 2019, has resulted in considerable focus on virulence abilities of coronavirus. Lectins are natural proteins with the ability to bind specific carbohydrates related to various microorganisms, including viruses, bacteria, fungi and parasites. Lectins have the ability to agglutinate and neutralize these pathogeneses. The delivery of the encapsulated antiviral agents or vaccines across the cell membrane can be possible by functionalized micellar and liposomal formulations. In this mini-review, recent advances and challenges related to important lectins with inhibition activities against coronaviruses are presented to obtain a novel viewpoint of microformulations or nanoformulations by micellar and liposomal cell-binding carriers.

Entities:  

Keywords:  COVID-19 pneumonia; coronaviruses; lectins; liposomes; micelles; nanoformulations

Year:  2020        PMID: 33297444      PMCID: PMC7762367          DOI: 10.3390/biomedicines8120580

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  104 in total

1.  Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.

Authors:  Na Zhang; Qineng Ping; Guihua Huang; Wenfang Xu; Yanna Cheng; Xiuzhen Han
Journal:  Int J Pharm       Date:  2006-07-21       Impact factor: 5.875

2.  A low-density lipoprotein receptor (LDLR) class A domain-containing C-type lectin from Litopenaeus vannamei plays opposite roles in antibacterial and antiviral responses.

Authors:  Zhiwei Liang; Linwei Yang; Jiefu Zheng; Hongliang Zuo; Shaoping Weng; Jianguo He; Xiaopeng Xu
Journal:  Dev Comp Immunol       Date:  2018-11-06       Impact factor: 3.636

3.  Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.

Authors:  Diego A Chiappetta; Christian Hocht; Javier A W Opezzo; Alejandro Sosnik
Journal:  Nanomedicine (Lond)       Date:  2012-11-22       Impact factor: 5.307

4.  Functionalized carbon-based nanomaterials and quantum dots with antibacterial activity: a review.

Authors:  Mehran Alavi; Erfan Jabari; Esmaiel Jabbari
Journal:  Expert Rev Anti Infect Ther       Date:  2020-09-08       Impact factor: 5.091

5.  Ultrasound assisted-phytofabricated Fe3O4 NPs with antioxidant properties and antibacterial effects on growth, biofilm formation, and spreading ability of multidrug resistant bacteria.

Authors:  Mehran Alavi; Naser Karimi
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

6.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

7.  Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.

Authors:  Xufang Deng; Sarah E StJohn; Heather L Osswald; Amornrat O'Brien; Bridget S Banach; Katrina Sleeman; Arun K Ghosh; Andrew D Mesecar; Susan C Baker
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

Review 8.  SARS: systematic review of treatment effects.

Authors:  Lauren J Stockman; Richard Bellamy; Paul Garner
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

9.  Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.

Authors:  Yi Jiang; Xu Cheng; Xiumei Zhao; Yan Yu; Mingyan Gao; Sheng Zhou
Journal:  Vaccine       Date:  2020-02-11       Impact factor: 3.641

10.  Characterization of a Novel Mannose-Binding Lectin with Antiviral Activities from Red Alga, Grateloupia chiangii.

Authors:  Hyun-Ju Hwang; Jin-Wook Han; Hancheol Jeon; Kichul Cho; Ju-Hee Kim; Dae-Sung Lee; Jong Won Han
Journal:  Biomolecules       Date:  2020-02-19
View more
  1 in total

Review 1.  Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.

Authors:  Ehsan Raoufi; Bahar Bahramimeimandi; M Salehi-Shadkami; Patcharida Chaosri; M R Mozafari
Journal:  Biomedicines       Date:  2021-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.